Quizartinib (AC220) is a second-generation FLT3 inhibitor that has shown promising activity in Phase II clinical trials. It inhibits mutant and wild-type FLT3 in vivo at 0.1 and 0.5 µM, respectively, and has shown favorable activity and tolerability in p
Molecular Weight:
560.7
Purity:
97% (HPLC)
CAS Number:
[950769-58-1]
Formula:
C29H32N6O4S
Target:
Flt3, P-glycoprotein, BCRP
* VAT and and shipping costs not included. Errors and price changes excepted